It is a pharma private limited company based in Pune City, Maharashtra, India, established in 2020.
2020 | Pune City, Maharashtra, India | ActiveBenatton Pharmaceutical Private Limited, a active private limited company, was established on 16 March 2020 in Pune City, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24299PN2020PTC190386. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Employing 9 professional, Its leadership includes Deepak Popatlal Oswal (Managing Director), Subodh Kumar Akhilesh Chandra Dubey (Director), Reena Subodh Dubey (Director). It holds ₹12.00 Cr open charges and ₹11.90 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ft No.1,Anchor House Condominium, Sahaney Sujan Park,Lullanagar, Pune City, Maharashtra, 411037.
U24299PN2020PTC190386
190386
16 March 2020
₹1.00 M
₹1.00 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Benatton Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Popatlal Oswal | Managing Director | 16 Mar 2020 | Current |
| Subodh Kumar Akhilesh Chandra Dubey | Director | 16 Mar 2020 | Current |
| Reena Subodh Dubey | Director | 16 Mar 2020 | Current |
| Vipul Mangilal Jain | Director | 16 Mar 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Benatton Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.46% increase. The company also saw a substantial improvement in profitability, with a 58.46% increase in profit. The company's net worth Soared by an impressive increase of 145.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Benatton Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹120,000,000.00
₹119,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Aug 2025 | Others | ₹2.00 Cr | Open |
| 28 Apr 2023 | Others | ₹10.00 Cr | Open |
| 06 Mar 2021 | Others | ₹7.00 Cr | Satisfied |
| 30 Dec 2020 | Others | ₹9.00 M | Satisfied |
| 10 Jul 2020 | Others | ₹4.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Benatton Pharmaceutical has a workforce of 9 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Benatton Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Benatton Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 20.00 M with Charge ID 101148989 was registered on 16 Aug 2025. was completed.
Progress on Benatton Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Benatton Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Progress on A charge registered on 30 Dec 2020 via Charge ID 100408299 with Others was fully satisfied on 04 Jul 2023. was documented.
A charge registered on 06 Mar 2021 via Charge ID 100459903 with Others was fully satisfied on 15 May 2023. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 100.00 M with Charge ID 100748895 was registered on 28 Apr 2023. was documented.
The CIN of Benatton Pharmaceutical Private Limited is U24299PN2020PTC190386.
Benatton Pharmaceutical Private Limited is headquartered at Ft No.1,Anchor House Condominium, Sahaney Sujan Park,Lullanagar, Pune City, Maharashtra, 411037.
Benatton Pharmaceutical Private Limited was incorporated on 16 March 2020.
The current directors of Benatton Pharmaceutical Private Limited are
The primary industry of Benatton Pharmaceutical Private Limited is Manufacturing.
Benatton Pharmaceutical Private Limited is unlisted.
The authorized capital of Benatton Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX